EU Announces Launch of ONCOVALUE Real-World Data Artificial Intelligence Initiative

A new initiative has been launched by the European Commission to promote the collection and use of real-world data (RWD) via artificial intelligence (AI). The project, called ONCOVALUE, will use these resources to help examine the performance and safety of new oncology drugs to support applications to health technology assessment (HTA) agencies.

According to Phil Taylor, “Among the aims of ONCOVALUE are to promote the introduction of cancer drugs and to identify patients who are unlikely to benefit from a new treatment, in order to avoid wastage of resources. That will be achieved by standardising data processing in hospitals so they can efficiently measure the cost effectiveness of new cancer therapies, according to BC Platforms.”

To read more, click here.

(Source: Pharmaphorum, November 25^th, 2022)